Blepharospasm Short Interval

Summary

The objective of this Phase II study is to show that pre-treated patients with BEB with the need of shortened injection intervals achieve an improved and stable quality of life level if they receive repeated NT 201 injections at short injection intervals. In addition, the tolerability of repeated shortened NT 201 administrations in patients with BEB including the development of neutralizing antibodies will be investigated.

Timeline

Start

2007-08

Primary completion

2008-02

Completion

2008-02

Outcome

Outcome not reported

Stopped: “primary efficacy endpoint not attainable.”

Drugs

Indications